Results 161 to 170 of about 4,109,495 (307)
Post-treatment adaptation experiences of women breast cancer survivors: a qualitative study. [PDF]
Bayrak NY, Özcan S, Turan GB.
europepmc +1 more source
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak +10 more
wiley +1 more source
S kakšnimi vprašanji se srečujejo sestre v zda
Virginia Coigney; priredba/adaptation: M.J.
doaj
Navigating international academic collaboration: The Arabic translation and cultural adaptation of the Quality Maternal and Newborn Care Framework index. [PDF]
Zaza K +7 more
europepmc +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Zaščitna cepljenja v otroški dobi
A. Wallgren; priredba/adaptation Hermina Andoljšek
doaj
Insights into a long life without cancer: The case of the bowhead whale
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley +1 more source
Zaščitna cepljenja v otroški dobi
A. Wallgren; priredba/adaptation Hermina Andoljšek
doaj
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source

